trending Market Intelligence /marketintelligence/en/news-insights/trending/iaw4z7jmjbi_zsgvzc7dkg2 content esgSubNav
In This List

Catalyst Pharmaceuticals names chief commercial officer

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Catalyst Pharmaceuticals names chief commercial officer

Catalyst Pharmaceuticals Inc. appointed Daniel Brennan as chief commercial officer.

Brennan will lead the biopharmaceutical company's marketing, sales and commercial operations. He most recently served as COO at Edge Therapeutics Inc.